Critical

Pulmonary haemorrhage in the newborn

Fresh blood from the airway · Paediatric
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Pulmonary haemorrhage is acute bleeding into the alveoli/airways, typically presenting as sudden deterioration with bloody frothy secretions from the endotracheal tube, usually in sick preterm infants and often linked to haemorrhagic pulmonary oedema (e.g. a large PDA, surfactant therapy or left ventricular failure). It is a life-threatening emergency requiring immediate ventilatory and circulatory support.

Red flags

  • Massive fresh blood filling the ETT with rapid desaturation
  • Haemodynamic collapse and shock
  • Disseminated intravascular coagulation
  • Refractory hypoxaemia despite high mean airway pressure
  • Large unrecognised PDA driving pulmonary oedema

Assessment

Differential diagnosis

  • Haemorrhagic pulmonary oedema (large left-to-right PDA shunt)
  • Severe respiratory distress syndrome with surfactant deficiency
  • Coagulopathy/DIC or inherited bleeding disorder
  • Sepsis with capillary leak
  • Congenital heart disease with heart failure
  • Traumatic airway bleeding from suction/intubation

Investigations

  • Chest radiograph (diffuse whiteout/ground-glass opacification)
  • Arterial blood gas (hypoxaemia, acidosis)
  • Full blood count, coagulation screen, fibrinogen and group/crossmatch
  • Echocardiography for PDA and cardiac function
  • Blood culture, CRP and glucose
  • Serial haematocrit

Management

  • Call for senior help; secure or confirm the airway and intubate if not already.
  • Increase mean airway pressure and PEEP (e.g. raise PEEP to 6–8 cmH2O) to tamponade alveolar bleeding and recruit lungs.
  • Increase FiO2 to maintain oxygenation and ventilate with adequate pressures.
  • Suction the ETT only enough to keep it patent – avoid vigorous suction that worsens bleeding.
  • Correct coagulopathy with fresh frozen plasma, platelets and cryoprecipitate/fibrinogen as indicated; give vitamin K if not already given.
  • Restore circulation with volume and packed red cells for significant blood loss; treat hypotension.
  • Identify and treat the cause: close a significant PDA, treat sepsis, support cardiac function.
  • Consider surfactant replacement after the acute bleed, as haemorrhage inactivates surfactant and this can improve oxygenation.
  • Consider HFOV for refractory oxygenation failure.
  • Maintain normothermia, normoglycaemia and normal calcium.
  • Monitor haematocrit, gases and chest radiograph serially.
  • Reassess volume status and ventilation frequently, weaning pressures as the bleeding settles.

Drugs & doses

Fresh frozen plasma 10–20 mL/kg IV for coagulopathy
Platelets 10–15 mL/kg IV for thrombocytopenia with active bleeding
Packed red cells 10–20 mL/kg IV for significant blood loss/anaemia
Vitamin K (phytomenadione) 1 mg IM/IV if not previously given
Poractant alfa (surfactant) 100–200 mg/kg intratracheal after acute haemorrhage to improve oxygenation
Dopamine 5–20 microgram/kg/min IV for hypotension

Disposition

NICU with HFOV and blood-product access; urgent senior neonatology and possibly cardiology input; tertiary/ECMO referral for refractory cases.

Complications & pitfalls

  • Hypovolaemic shock and cardiac arrest
  • Intraventricular haemorrhage
  • Chronic lung disease after major injury
  • Multi-organ dysfunction from hypoxia/hypotension
  • Recurrent haemorrhage
  • Death

Exam pearls

  • Raising PEEP/mean airway pressure helps tamponade alveolar bleeding – resist the urge to reduce pressures.
  • A large PDA is a common precipitant, especially after surfactant – echo and treat it.
  • Avoid over-vigorous ETT suction, which perpetuates bleeding.
  • Give surfactant AFTER the acute bleed to overcome surfactant inactivation.
  • Correct coagulopathy aggressively and crossmatch early.

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.